NICE recommends targeted treatment for neuroendocrine cancer in the liver
Posted:
People with neuroendocrine tumours (NETs) in the liver could benefit from a therapy that targets tumours with radiation while limiting exposure to healthy surrounding tissue, according to new guidance from the National Institute for Health and Care Excellence (NICE). NETs are cancers of neuroendocrine cells commonly spread from organs such as the gastrointestinal tract or pancreas to the liver. The guidance is significant as it offers another option for healthcare professionals to treat patients within the National Health Service in England and Wales.
As general-purpose AI like ChatGPT and Gemini make its way into people's everyday lives today, domain-specific ones like AI in cancer are also advancing, with only funding and critical infrastructure standing in the way of clinical use, according to one…
Infrastructure is easy to overlook and underinvest in. Roads, bridges, and electrical grids fade into the background, until a failure makes them impossible to ignore.
The same is becoming true for AI in healthcare. Over the past several years, health…
Attendees
Sponsors and Exhibitors
Contact us